Importantly, the stimulation of phospholipid secretion may be a key therapeutic mechanism of several established and new drugs such ursodeoxycholic acid, obeticholic acid (as well as other farnesoid X receptor agonists), and fibrates for treatment of cholangiopathies such as PBC and PSC.2 Here, NR1H4 is linked to primary biliary cholangitis.